Observe Medical (Norway) Performance
| OBSRV Stock | NOK 4.61 0.71 18.21% |
The company holds a Beta of 1.83, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Observe Medical will likely underperform. At this point, Observe Medical Asa has a negative expected return of -0.18%. Please make sure to check Observe Medical's downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Observe Medical Asa performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Observe Medical Asa has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
| Begin Period Cash Flow | 18.9 M | |
| Total Cashflows From Investing Activities | -4.9 M |
Observe |
Observe Medical Relative Risk vs. Return Landscape
If you would invest 596.00 in Observe Medical Asa on December 2, 2024 and sell it today you would lose (135.00) from holding Observe Medical Asa or give up 22.65% of portfolio value over 90 days. Observe Medical Asa is generating negative expected returns and assumes 7.0395% volatility on return distribution over the 90 days horizon. Simply put, 62% of stocks are less volatile than Observe, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Observe Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Observe Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Observe Medical Asa, and traders can use it to determine the average amount a Observe Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0257
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OBSRV |
Estimated Market Risk
| 7.04 actual daily | 62 62% of assets are less volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Observe Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Observe Medical by adding Observe Medical to a well-diversified portfolio.
Observe Medical Fundamentals Growth
Observe Stock prices reflect investors' perceptions of the future prospects and financial health of Observe Medical, and Observe Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Observe Stock performance.
| Return On Equity | -0.57 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (2.44) % | |||
| Operating Margin | (2.65) % | |||
| Current Valuation | 137.49 M | |||
| Shares Outstanding | 53.49 M | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 6.76 X | |||
| Revenue | 24.04 M | |||
| EBITDA | (19.53 M) | |||
| Cash And Equivalents | 2.86 M | |||
| Cash Per Share | 0.72 X | |||
| Total Debt | 550 K | |||
| Debt To Equity | 4.05 % | |||
| Book Value Per Share | 3.01 X | |||
| Cash Flow From Operations | (22.13 M) | |||
| Earnings Per Share | (0.57) X | |||
| Total Asset | 71.74 M | |||
About Observe Medical Performance
By examining Observe Medical's fundamental ratios, stakeholders can obtain critical insights into Observe Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Observe Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Observe Medical ASA develops and markets medical technology products for patients, healthcare professionals, and hospitals in Europe and the United States. The company was founded in 2009 and is headquartered in Oslo, Norway. OBSERVE MEDICAL is traded on Oslo Stock Exchange in Norway.Things to note about Observe Medical Asa performance evaluation
Checking the ongoing alerts about Observe Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Observe Medical Asa help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Observe Medical Asa generated a negative expected return over the last 90 days | |
| Observe Medical Asa has high historical volatility and very poor performance | |
| Observe Medical Asa has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 24.04 M. Net Loss for the year was (26.32 M) with profit before overhead, payroll, taxes, and interest of 9.52 M. | |
| Observe Medical Asa has accumulated about 2.86 M in cash with (22.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72. | |
| Roughly 55.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Observe Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Observe Medical's stock is overvalued or undervalued compared to its peers.
- Examining Observe Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Observe Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Observe Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Observe Medical's stock. These opinions can provide insight into Observe Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Observe Stock
Observe Medical financial ratios help investors to determine whether Observe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Observe with respect to the benefits of owning Observe Medical security.